Mortality Burden for Patients With Untreated Aortic Regurgitation
In patients with untreated AR, LV remodeling, left atrial remodeling, and other markers of cardiac damage are associated with substantial mortality risk, both for severe and moderate AR. Further study is needed to determine whether AVR is warranted in patients with less-than-severe AR with at-risk factors.
Authors
- Philippe Généreux (ORCID: https://orcid.org/0000-0002-5507-3712)
- Vinod H. Thourani (ORCID: https://orcid.org/0000-0002-9309-2623)
- Patricia A. Pellikka (ORCID: https://orcid.org/0000-0001-6800-3521)
- Nicholas Amoroso (ORCID: https://orcid.org/0000-0001-6785-6899)
- Linda D. Gillam (ORCID: https://orcid.org/0000-0002-1716-7574)
- Michael Dobbles
- Duane S. Pinto (ORCID: https://orcid.org/0000-0002-2309-8480)
- Evelio Rodríguez (ORCID: https://orcid.org/0000-0002-9646-4314)
- Michelle Kwon
- Rahul P. Sharma
Institutions
- Saint Thomas West Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Valve (United States) (US)
- Mayo Clinic (US)
- Harvard University (US)
- Medical University of South Carolina (US)
- Morristown Medical Center (US)
- JenaValve (United States) (US)
- Soka University of America (US)
- Stanford University (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.jacadv.2024.101228
- Citations
- 10
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.02